Company: IMCR
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012123
Chunk: 46

Company: Immunocore Holdings plc
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 46
---
 similar programs; |

| • | when required, reviewing and discussing with management our Compensation Discussion and Analysis section of our annual reports, registration statements, proxy statements, or information statements filed with the SEC; |

| • | reviewing and discussing with management any conflicts of interest raised; |

| • | overseeing the preparation of any report required by applicable U.S. and U.K. rules and regulations to be included in our public filings relating to compensation policy and practices, including but not limited to the directors’ remuneration report required under the Companies Act; and |

| • | overseeing “clawback” or similar policies allowing us to recoup compensation paid to employees. |

Additionally, the remuneration committee was responsible for reviewing and recommending to the board of directors for its approval the type and amount of compensation to be paid or awarded to members of the board of directors until December 5, 2024, at which time this responsibility was moved to the nominating and corporate governance committee. The remuneration committee may form and delegate authority to one or more subcommittees composed of one or more of its members for any purpose that the remuneration committee deems appropriate, and may delegate to such subcommittees such power and authority as the remuneration committee deems appropriate, in all cases to the extent consistent with our articles of association, the Nasdaq listing rules and other applicable law. See the section of this proxy statement titled “Executive Compensation—Compensation Discussion and Analysis” for a discussion of the role of our executive officers and compensation consultant in determining executive compensation. Remuneration Committee Interlocks and Insider Participation No member of our remuneration committee is currently one of our officers or employees. None of our executive officers currently serves, or has served during the last year, as a member of the board of directors or remuneration committee of any entity that has one or more executive officers serving as a member of our board of directors or remuneration committee. Nominating and Corporate Governance Committee Our nominating and corporate governance committee is composed of Professor Sir Bell, Mr. Perez, Ms. Peterson and Professor Sir Ratcliffe, and assists our board of directors in identifying individuals qualified to become members of our board and executive officers consistent with criteria established by our board and in developing our corporate governance principles. Mr. Perez serves as chairman of the nominating and corporate governance committee. The nominating and corporate governance committee’s responsibilities include:

| • | identifying and evaluating candidates, including nomination of incumbent directors for re-election and nominees recommended by